This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Amersham Plc, Molecular Neuroimaging, LLC.. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2010
Title: The Innovations of Gilles D Tamagnan
Introduction
Gilles D Tamagnan is a notable inventor based in Woodbridge, CT (US). He has made significant contributions to the field of neuroimaging and therapeutic compounds, holding a total of 2 patents. His work focuses on advancing methods for diagnosing and treating neurological conditions.
Latest Patents
One of his latest patents is titled "Compounds and amyloid probes thereof for therapeutic and imaging uses." This invention provides compounds and amyloid probes that enable an antemortem method of diagnosing Alzheimer's Disease (AD) and quantifying the extent of amyloid deposits in the brain through in vivo imaging. The amyloid probes can cross the blood-brain barrier and differentiate between AD-affected brains and normal brains. They can be administered in suitable amounts for imaging purposes and may also be used in the treatment of diseases such as AD and type 2 diabetes mellitus.
Another significant patent is "Neuroprobes for mapping monoamine reuptake sites." This invention involves iodinated neuroprobes that serve as radiotracers for imaging monoamine reuptake sites in the brain using techniques like single-photon emission computed tomography (SPECT) and positron emission tomography (PET). The patent also includes precursors for preparing these radiolabeled neuroprobes.
Career Highlights
Gilles D Tamagnan has worked with several prominent companies in the field, including Molecular Neuroimaging, LLC and Amersham Plc. His experience in these organizations has contributed to his expertise in neuroimaging and the development of innovative compounds.
Collaborations
Throughout his career, he has collaborated with notable individuals such as David Alagille and Robert B Innis. These partnerships have likely enhanced his research and development efforts in the field of neuroimaging.
Conclusion
Gilles D Tamagnan's contributions to the field of neuroimaging and therapeutic compounds are noteworthy. His innovative patents reflect his commitment to advancing medical science and improving diagnostic methods for neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile